title: The economic case for combating malaria.
abstract: To date, existing studies focus largely on the economic detriments of malaria. However, if we are to create suitable incentives for larger-scale, more sustained anti-malaria efforts from a wider group of stakeholders, we need a much better understanding of the economic benefits of malaria reduction and elimination. Our report seeks to rectify this disjuncture by showing how attaining the funding needed to meet internationally agreed targets for malaria elimination would, on conservative assumptions, generate enormous economic improvements. We use a cost-benefit analysis anchored in Global Malaria Action Plan projections of malaria eradication based on fully met funding goals. By calculating the value of economic output accrued caused by work years saved and subtracting the costs of intervention, we find that malaria reduction and elimination during 2013-2035 has a 2013 net present value of US $208.6 billion.
authors.forename: Mark
authors.initials: M
authors.lastname: Purdy
authors.forename: Matthew
authors.initials: M
authors.lastname: Robinson
authors.forename: Kuangyi
authors.initials: K
authors.lastname: Wei
authors.forename: David
authors.initials: D
authors.lastname: Rublin
mesh_terms: D000962:Antimalarials / Q000138:chemical synthesis / Q000627:therapeutic use; D003362:Cost-Benefit Analysis / Q000706:statistics & numerical data; D060740:Disease Eradication / Q000191:economics* / Q000458:organization & administration; D014943:Global Health / Q000191:economics*; D006801:Humans; D007391:International Cooperation; D008288:Malaria / Q000188:drug therapy / Q000191:economics* / Q000517:prevention & control*
chemical_list: D000962:Antimalarials